| scholarly article | Q13442814 |
| P50 | author | Johann Colomba | Q91989879 |
| P2093 | author name string | Rémi Rabasa-Lhoret | |
| Kenneth Cusi | |||
| François Tremblay | |||
| Adèle Coriati | |||
| Valérie Boudreau | |||
| Julio A Leey | |||
| Catherine Lehoux-Dubois | |||
| Silvia R Netedu | |||
| P2860 | cites work | Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus | Q28395801 |
| Cirrhosis and other liver disease in cystic fibrosis | Q28660820 | ||
| Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence | Q33954722 | ||
| Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society | Q34351928 | ||
| Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage | Q34706104 | ||
| Clinical importance of cystic fibrosis-related diabetes | Q36033722 | ||
| Diabetes: a major co-morbidity of cystic fibrosis. | Q36248884 | ||
| Management of cystic fibrosis-related diabetes | Q37259700 | ||
| Discriminatory value of alanine aminotransferase for diabetes prediction: the Insulin Resistance Atherosclerosis Study | Q37359561 | ||
| Early lung disease in cystic fibrosis | Q38178771 | ||
| Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | Q38365928 | ||
| Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes | Q38746353 | ||
| Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity? | Q50654521 | ||
| Combined Exercise Training Improves Glycemic Control in Adult with Cystic Fibrosis. | Q51460809 | ||
| Cystic fibrosis-related diabetes is caused by islet loss and inflammation. | Q52579658 | ||
| Update on cystic fibrosis-related diabetes | Q86549849 | ||
| Impact of sex on insulin secretion in cystic fibrosis | Q87135775 | ||
| How patients' representations of cystic fibrosis-related diabetes inform their health behaviours | Q89294024 | ||
| The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity | Q91316771 | ||
| Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges | Q38979834 | ||
| The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis | Q38980646 | ||
| Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus | Q39002475 | ||
| A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease | Q42379258 | ||
| The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease. | Q43786135 | ||
| High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes | Q44007236 | ||
| Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis | Q46121998 | ||
| Clinical Characteristics of Cystic Fibrosis Patients Prior to Lung Transplantation: An International Comparison between Canada and the United States | Q47225533 | ||
| The Role of Estrogens in Pancreatic Islet Physiopathology | Q47311504 | ||
| Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis | Q47641184 | ||
| Nonalcoholic steatohepatitis in nonobese patients: Not so different after all. | Q48040786 | ||
| High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. | Q48085253 | ||
| Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis. | Q48191216 | ||
| Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease | Q49334378 | ||
| Cystic Fibrosis-related cirrhosis | Q49551174 | ||
| Pancreatic insufficiency in Cystic Fibrosis | Q49551255 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | e0219855 | |
| P577 | publication date | 2019-07-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis | |
| P478 | volume | 14 |
Search more.